Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Sandoz Group Ag (0SAN) Share Price

Price 47.56395 on 13-08-2025 at 18:15:01
Change 0.00 0%
Buy 0.00
Sell 0.00
Last Trade: Unknown 428.00 at 47.56395
Day's Volume: 83,389
Last Close: 47.56395
Open: 0.00
ISIN: CH1243598427
Day's Range 0.00 - 0.00
52wk Range: 30.61 - 49.36854
Market Capitalisation: -
VWAP: 47.5351
Shares in Issue: 430.70m

Sandoz Group Ag (0SAN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 428 47.56395 SI Trade
Negotiated Trade
17:35:16 - 13-Aug-25
Unknown* 4,998 47.53674 SI Trade
Negotiated Trade
17:02:23 - 13-Aug-25
Unknown* 49 47.83 SI Trade
Negotiated Trade
16:49:19 - 13-Aug-25
Unknown* 150 47.83 SI Trade
16:30:46 - 13-Aug-25
Unknown* 443 47.83 SI Trade
16:30:46 - 13-Aug-25
Unknown* 59 47.83 SI Trade
16:30:46 - 13-Aug-25
Unknown* 79 47.83 OTC Trade
16:30:43 - 13-Aug-25
Unknown* 154 47.83 OTC Trade
16:30:43 - 13-Aug-25
Unknown* 0 47.56 SI Trade
16:29:44 - 13-Aug-25
Unknown* 731 47.55 SI Trade
16:19:23 - 13-Aug-25
See more Sandoz Group Ag trades

Sandoz Group Ag (0SAN) Share Price History

Time period:
to
Date Open High Low Close Volume
13th Aug 2025 (Wed) 47.56395 47.56395 47.56395 47.56395 83,389
12th Aug 2025 (Tue) 47.30624 47.30624 47.30624 47.30624 663,579
11th Aug 2025 (Mon) 47.07566 47.07566 47.07566 47.07566 29,008
8th Aug 2025 (Fri) 48.26607 48.26607 48.26607 48.26607 122,902
7th Aug 2025 (Thu) 49.36854 49.36854 49.36854 49.36854 308,914
6th Aug 2025 (Wed) 45.22 45.22 45.22 45.22 90,784
5th Aug 2025 (Tue) 46.02172 46.02172 46.02172 46.02172 440,079
4th Aug 2025 (Mon) 46.12786 46.12786 46.12786 46.12786 101,270
1st Aug 2025 (Fri) 46.94 46.94 46.94 46.94 0
31st Jul 2025 (Thu) 46.94 46.94 46.94 46.94 66,578
30th Jul 2025 (Wed) 48.21504 48.21504 48.21504 48.21504 136,211
29th Jul 2025 (Tue) 47.6873 47.6873 47.6873 47.6873 84,110
28th Jul 2025 (Mon) 47.81875 47.81875 47.81875 47.81875 74,056
25th Jul 2025 (Fri) 47.68576 47.68576 47.68576 47.68576 108,662
24th Jul 2025 (Thu) 47.79 47.79 47.79 47.79 53,737
23rd Jul 2025 (Wed) 47.17667 47.17667 47.17667 47.17667 15,238
22nd Jul 2025 (Tue) 45.8855 45.8855 45.8855 45.8855 15,788
21st Jul 2025 (Mon) 45.95 45.95 45.95 45.95 29,107
18th Jul 2025 (Fri) 45.465 45.465 45.465 45.465 34,003
17th Jul 2025 (Thu) 44.89 44.89 44.89 44.89 88,661
16th Jul 2025 (Wed) 44.99 44.99 44.99 44.99 101,136
15th Jul 2025 (Tue) 45.235 45.235 45.235 45.235 113,623
14th Jul 2025 (Mon) 44.79037 44.79037 44.79037 44.79037 28,275
See more Sandoz Group Ag price history

Sandoz Group Ag (0SAN) Regulatory News

Date Source Headline
12th Aug 2025 6:00 am GNW Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
7th Aug 2025 6:00 am GNW Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
30th Jul 2025 6:15 am GNW Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
1st Jul 2025 1:56 pm GNW Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
2nd Jun 2025 6:00 am GNW Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
21st May 2025 4:30 pm GNW Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
30th Apr 2025 6:00 am GNW Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
29th Apr 2025 4:00 pm GNW Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
15th Apr 2025 12:50 pm GNW Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
14th Apr 2025 3:00 pm GNW [Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
See more Sandoz Group Ag regulatory news
FTSE 100 Latest
Value9,165.23
Change17.42

Login to your account

Forgot Password?

Not Registered